These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21442973)

  • 1. [Therapeutic potential of thyreoliberin (TRH) and its analogues as antiepileptic and neuroprotective drugs].
    Jantas D
    Przegl Lek; 2010; 67(11):1179-85. PubMed ID: 21442973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics.
    Gary KA; Sevarino KA; Yarbrough GG; Prange AJ; Winokur A
    J Pharmacol Exp Ther; 2003 May; 305(2):410-6. PubMed ID: 12606661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroprotective activity of antiepileptic drugs].
    Czuczwar K; Czuczwar M; Cieszczyk J; Gawlik P; Luszczki JJ; Borowicz KK; Czuczwar SJ
    Przegl Lek; 2004; 61(11):1268-71. PubMed ID: 15727029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats.
    Heuer H; Schäfer MK; O'Donnell D; Walker P; Bauer K
    J Comp Neurol; 2000 Dec; 428(2):319-36. PubMed ID: 11064370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone in the treatment of intractable epilepsy.
    Kubek MJ; Garg BP
    Pediatr Neurol; 2002 Jan; 26(1):9-17. PubMed ID: 11814729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone: role in the treatment of West syndrome and related epileptic encephalopathies.
    Takeuchi Y; Takano T; Abe J; Takikita S; Ohno M
    Brain Dev; 2001 Nov; 23(7):662-7. PubMed ID: 11701274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel thioamide analogues of TRH with selective activity on CNS.
    Alexandrová M; Strbák V; Kruszynski M; Zboinska J; Kupryszewski G
    Gen Physiol Biophys; 1991 Jun; 10(3):287-97. PubMed ID: 1655558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
    Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W
    Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TRH and its analogues on primary cortical neuronal cell damage induced by various excitotoxic, necrotic and apoptotic agents.
    Jantas D; Jaworska-Feil L; Lipkowski AW; Lason W
    Neuropeptides; 2009 Oct; 43(5):371-85. PubMed ID: 19666192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyrotropin-releasing hormone: distribution, role and importance].
    Jovanović-Mićić D; Samardzić R; Beleslin D
    Srp Arh Celok Lek; 1991; 119(9-10):263-70. PubMed ID: 1806996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions.
    Yarbrough GG; Kamath J; Winokur A; Prange AJ
    Med Hypotheses; 2007; 69(6):1249-56. PubMed ID: 17553626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone (TRH) and circulatory shock.
    McIntosh TK; Faden AI
    Circ Shock; 1986; 18(3):241-58. PubMed ID: 3084122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection and neurodegenerative disease.
    Vajda FJ
    J Clin Neurosci; 2002 Jan; 9(1):4-8. PubMed ID: 11749009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone (TRH) analogues that exhibit selectivity to TRH receptor subtype 2.
    Kaur N; Lu X; Gershengorn MC; Jain R
    J Med Chem; 2005 Sep; 48(19):6162-5. PubMed ID: 16162016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrally acting and metabolically stable thyrotropin-releasing hormone analogues by replacement of histidine with substituted pyridinium.
    Prokai L; Prokai-Tatrai K; Zharikova AD; Nguyen V; Perjesi P; Stevens SM
    J Med Chem; 2004 Nov; 47(24):6025-33. PubMed ID: 15537357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
    Belcastro V; Pierguidi L; Tambasco N
    Brain Dev; 2011 Apr; 33(4):289-93. PubMed ID: 20630672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRH increases cerebrospinal fluid concentration of kynurenine.
    Takeuchi Y; Matsushita H; Kawano H; Sakai H; Yoshimoto K; Sawada T
    Neuroreport; 1999 Nov; 10(17):3601-3. PubMed ID: 10619651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone (TRH), a signal peptide of the central nervous system.
    Heuer H; Schäfer MK; Bauer K
    Acta Med Austriaca; 1999; 26(4):119-22. PubMed ID: 10526628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel neuroprotective tripeptides and dipeptides.
    Faden AI; Knoblach SM; Movsesyan VA; Lea PM; Cernak I
    Ann N Y Acad Sci; 2005 Aug; 1053():472-81. PubMed ID: 16179555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.